WAKSAL HARLAN (Executive Chair) received a stock award from LYRA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/20/2024ACC: 0000950170-24-034350
DirectorOfficer· Executive Chair
Since Feb 2022
+275K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
275K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+275K
Price / share
—
Trade value
—
% of position
105.0%
3/18/2024
261.97K→536.97K
Total
Net shares
+275K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2024 | A · Award | +275K | — | — | 105.0% | 261.97K | 536.97K |
| Total | +275K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported